Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K F Adams

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Research Report (Health Effects Institute)|May 1, 1991
Effects of 4 percent and 6 percent carboxyhemoglobin on arrhythmia production in patients with coronary artery diseaseD S Sheps, M C Herbst, A L Hinderliter, et al.
Circulation|April 13, 1999
Gender differences in survival in advanced heart failure. Insights from the FIRST studyK F Adams, C A Sueta, M Gheorghiade, et al.
Annals of Internal Medicine|September 1, 1990
Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery diseaseD S Sheps, M C Herbst, A L Hinderliter, et al.
American Heart Journal|July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor, W A Gattis, B F Uretsky, et al.
Circulation|December 1, 1996
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA InvestigatorsM R Bristow, E M Gilbert, W T Abraham, et al.
American Heart Journal|January 5, 2000
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failureM S Cuffe, R M Califf, K F Adams, et al.
American Heart Journal|July 1, 1997
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)R M Califf, K F Adams, W J McKenna, et al.
Pediatric Obesity|May 17, 2013
Prevalence of obesity and extreme obesity in children aged 3-5 yearsJ C Lo, B Maring, M Chandra, et al.
Pediatric Obesity|January 23, 2015
Comparing US paediatric and adult weight classification at the transition from late teenage to young adulthoodB Maring, L C Greenspan, M Chandra, et al.
The New England Journal of Medicine|July 8, 2011
Effect of nesiritide in patients with acute decompensated heart failureC M O'Connor, R C Starling, A F Hernandez, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Research Report (Health Effects Institute)|May 1, 1991
Effects of 4 percent and 6 percent carboxyhemoglobin on arrhythmia production in patients with coronary artery diseaseD S Sheps, M C Herbst, A L Hinderliter, et al.
Circulation|April 13, 1999
Gender differences in survival in advanced heart failure. Insights from the FIRST studyK F Adams, C A Sueta, M Gheorghiade, et al.
Annals of Internal Medicine|September 1, 1990
Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery diseaseD S Sheps, M C Herbst, A L Hinderliter, et al.
American Heart Journal|July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor, W A Gattis, B F Uretsky, et al.
Circulation|December 1, 1996
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA InvestigatorsM R Bristow, E M Gilbert, W T Abraham, et al.
American Heart Journal|January 5, 2000
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failureM S Cuffe, R M Califf, K F Adams, et al.
American Heart Journal|July 1, 1997
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)R M Califf, K F Adams, W J McKenna, et al.
Pediatric Obesity|May 17, 2013
Prevalence of obesity and extreme obesity in children aged 3-5 yearsJ C Lo, B Maring, M Chandra, et al.
Pediatric Obesity|January 23, 2015
Comparing US paediatric and adult weight classification at the transition from late teenage to young adulthoodB Maring, L C Greenspan, M Chandra, et al.
The New England Journal of Medicine|July 8, 2011
Effect of nesiritide in patients with acute decompensated heart failureC M O'Connor, R C Starling, A F Hernandez, et al.
Pageof 6